There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.

The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...

At Sanford Health in Bismarck, doctors have now performed 500 transcatheter aortic valve replacements, known as TAVR.

The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Citation: Song Y, Zhang X, Zhou D and Pan W (2025) Case Report: The second valve drag technique for managing acute total obstruction of the right coronary artery during transcatheter aortic valve ...

Sutureless Aortic Valve & Stentless Valves Stentless Valves In order to improve hemodynamics, especially in a small annulus (21–19 mm), stentless bioprosthesis has been developed. [13–16 ...

Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with aortic stenosis; however, the optimal postoperative anticoagulation therapy for patients with atrial fibrillation ...

Dynamic models incorporate changes over time and may improve accuracy and fairness in hospital comparisons. This study evaluated whether dynamic updating, compared with a static model, altered ...